vs
Side-by-side financial comparison of Huntington Ingalls Industries (HII) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Huntington Ingalls Industries is the larger business by last-quarter revenue ($1.7B vs $1.5B, roughly 1.1× BeOne Medicines Ltd.). Huntington Ingalls Industries runs the higher net margin — 8.9% vs 4.4%, a 4.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 13.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-461.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -25.2%).
Huntington Ingalls Industries, Inc. (HII) is the largest military shipbuilding company in the United States as well as a provider of professional services to partners in government and industry. HII was formed on 31 March 2011, as a divestiture from Northrop Grumman.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
HII vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.5B |
| Net Profit | $149.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 9.3% | 12.4% |
| Net Margin | 8.9% | 4.4% |
| Revenue YoY | 13.8% | 32.8% |
| Net Profit YoY | — | 143.8% |
| EPS (diluted) | $3.79 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.7B | — | ||
| Q4 25 | $3.5B | $1.5B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.1B | $1.3B | ||
| Q1 25 | $2.7B | $1.1B | ||
| Q4 24 | $3.0B | $1.1B | ||
| Q3 24 | $2.7B | $1.0B | ||
| Q2 24 | $3.0B | $929.2M |
| Q1 26 | $149.0M | — | ||
| Q4 25 | $159.0M | $66.5M | ||
| Q3 25 | $145.0M | $124.8M | ||
| Q2 25 | $152.0M | $94.3M | ||
| Q1 25 | $149.0M | $1.3M | ||
| Q4 24 | $123.0M | $-151.9M | ||
| Q3 24 | $101.0M | $-121.3M | ||
| Q2 24 | $173.0M | $-120.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
| Q1 26 | 9.3% | — | ||
| Q4 25 | 4.9% | 12.4% | ||
| Q3 25 | 5.0% | 11.5% | ||
| Q2 25 | 5.3% | 6.7% | ||
| Q1 25 | 5.9% | 1.0% | ||
| Q4 24 | 3.7% | -7.0% | ||
| Q3 24 | 3.0% | -12.0% | ||
| Q2 24 | 6.3% | -11.5% |
| Q1 26 | 8.9% | — | ||
| Q4 25 | 4.6% | 4.4% | ||
| Q3 25 | 4.5% | 8.8% | ||
| Q2 25 | 4.9% | 7.2% | ||
| Q1 25 | 5.4% | 0.1% | ||
| Q4 24 | 4.1% | -13.5% | ||
| Q3 24 | 3.7% | -12.1% | ||
| Q2 24 | 5.8% | -13.0% |
| Q1 26 | $3.79 | — | ||
| Q4 25 | $4.06 | $0.05 | ||
| Q3 25 | $3.68 | $0.08 | ||
| Q2 25 | $3.86 | $0.06 | ||
| Q1 25 | $3.79 | $0.00 | ||
| Q4 24 | $3.15 | $-0.10 | ||
| Q3 24 | $2.56 | $-0.09 | ||
| Q2 24 | $4.38 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.0M | $4.5B |
| Total DebtLower is stronger | $2.7B | $836.4M |
| Stockholders' EquityBook value | $5.1B | $4.4B |
| Total Assets | $12.5B | $8.2B |
| Debt / EquityLower = less leverage | 0.52× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $216.0M | — | ||
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.6B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.1B | $4.4B | ||
| Q3 25 | $5.0B | $4.1B | ||
| Q2 25 | $4.9B | $3.8B | ||
| Q1 25 | $4.8B | $3.5B | ||
| Q4 24 | $4.7B | $3.3B | ||
| Q3 24 | $4.2B | $3.4B | ||
| Q2 24 | $4.2B | $3.4B |
| Q1 26 | $12.5B | — | ||
| Q4 25 | $12.7B | $8.2B | ||
| Q3 25 | $12.3B | $7.6B | ||
| Q2 25 | $12.1B | $6.3B | ||
| Q1 25 | $12.1B | $5.8B | ||
| Q4 24 | $12.1B | $5.9B | ||
| Q3 24 | $11.1B | $5.8B | ||
| Q2 24 | $11.3B | $5.7B |
| Q1 26 | 0.52× | — | ||
| Q4 25 | 0.53× | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-390.0M | $417.3M |
| Free Cash FlowOCF − Capex | $-461.0M | $379.8M |
| FCF MarginFCF / Revenue | -27.7% | 25.4% |
| Capex IntensityCapex / Revenue | 4.4% | 2.5% |
| Cash ConversionOCF / Net Profit | -2.62× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $795.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-390.0M | — | ||
| Q4 25 | $650.0M | $417.3M | ||
| Q3 25 | $118.0M | $402.6M | ||
| Q2 25 | $823.0M | $263.6M | ||
| Q1 25 | $-395.0M | $44.1M | ||
| Q4 24 | $391.0M | $75.2M | ||
| Q3 24 | $213.0M | $188.4M | ||
| Q2 24 | $-9.0M | $-95.6M |
| Q1 26 | $-461.0M | — | ||
| Q4 25 | $516.0M | $379.8M | ||
| Q3 25 | $13.0M | $354.5M | ||
| Q2 25 | $727.0M | $219.8M | ||
| Q1 25 | $-462.0M | $-12.3M | ||
| Q4 24 | $277.0M | $-17.3M | ||
| Q3 24 | $125.0M | $54.7M | ||
| Q2 24 | $-99.0M | $-205.5M |
| Q1 26 | -27.7% | — | ||
| Q4 25 | 14.8% | 25.4% | ||
| Q3 25 | 0.4% | 25.1% | ||
| Q2 25 | 23.6% | 16.7% | ||
| Q1 25 | -16.9% | -1.1% | ||
| Q4 24 | 9.2% | -1.5% | ||
| Q3 24 | 4.5% | 5.5% | ||
| Q2 24 | -3.3% | -22.1% |
| Q1 26 | 4.4% | — | ||
| Q4 25 | 3.9% | 2.5% | ||
| Q3 25 | 3.3% | 3.4% | ||
| Q2 25 | 3.1% | 3.3% | ||
| Q1 25 | 2.5% | 5.0% | ||
| Q4 24 | 3.8% | 8.2% | ||
| Q3 24 | 3.2% | 13.3% | ||
| Q2 24 | 3.0% | 11.8% |
| Q1 26 | -2.62× | — | ||
| Q4 25 | 4.09× | 6.28× | ||
| Q3 25 | 0.81× | 3.22× | ||
| Q2 25 | 5.41× | 2.79× | ||
| Q1 25 | -2.65× | 34.71× | ||
| Q4 24 | 3.18× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | -0.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
